Glenmede Trust CO Na Opti Nose, Inc. Call Options Transaction History
Glenmede Trust CO Na
- $18.2 Billion
 - Q1 2025
 
Call Options
	  0 transactions
	
  | Quarter | Operation | Price Per call | calls change | calls Held | SEC Form | 
|---|
Others Institutions Holding OPTN
# of Institutions
2Shares Held
5.29MCall Options Held
0Put Options Held
0About OptiNose, Inc.
- Ticker OPTN
 - Exchange NASDAQ
 - Sector Healthcare
 - Industry Drug Manufacturers—Specialty & Generic
 - Shares Outstandng 83,277,504
 - Market Cap $799M
 - Description
 - OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...